Find your next paid study

University of Maryland, BaltimoreNCT06199154

A First Human Dose Study Investigating Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of Single and Multiple Ascending Doses of NNC6989-0001 in Healthy Participants With Overweight or Obesity

This study is testing a new medicine, NNC6989-0001, to test it is safe and tolerable for healthy people living with overweight or obesity. NNC6989-0001 is stil…

OverweightObesity

Novo Nordisk A/SNCT07437079

~$10 – $7,500

Observational

The Fast In-Bed Tracking (FIT) System Lifestyle Intervention

This project will complete the final design and development steps to commercialize the Fast In-Bed Tracking (FIT) Platform, which is an e-Health and wellness I…

Disability PhysicalWheelchairObesity; Overweight

Jonathan PearlmanNCT07141342

~$10 – $7,500

Phase 2

A Randomized-Controlled Trial of Semaglutide for Patients With Chronic Low Back Pain and Obesity

Low back pain is the leading cause of disability in the United States, and obesity is a major risk factor for its development. GLP-1 receptor agonists such as …

Lower Back PainObesity (BMI>30)Chronic Lower Back Pain+1 more

Washington University School of MedicineNCT07731256

Obesity (BMI>30)Insulin Resistance

Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity

Determine the impact of obesity with insulin resistance on the neurovascular response to brain insulin stimulation.

University of Missouri-ColumbiaNCT07653464

ObesityVasodilationHealthy

Sex Disparities in Hypoxic Vasodilation and Impact of Obesity

The purpose of this project is to examine key mechanisms contributing to sex-differences in hypoxic vasodilation and the impact of obesity, with particular emp…

University of Missouri-ColumbiaNCT05219799

Pharmacogenetics of Response to GLP1R Agonists

Overweight/obese otherwise healthy volunteers will be recruited from the Old Order Amish population in Lancaster County, PA. Lancaster County, PA. Pharmacodyna…

ObesityDiabetes Type 2

University of Maryland, BaltimoreNCT05071898

Phase 4

A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of Topical-Lingual Semaglutide (T-L Semaglutide) in Adults With Obesity

This study investigates the Topical-Lingual (T-L) delivery of semaglutide, a GLP-1 receptor agonist (GLP-1RA), via an oral liquid emulsion formulation as a Pro…

Obesity & Overweight

Gila Therapeutics, Inc.NCT07728383

~$10 – $8,750

Phase 4

Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1-based Therapy Discontinuation

This study will compare the effect of orforglipron and phentermine on weight maintenance.

Obesity

Massachusetts General HospitalNCT07729332

Phase 2

Sit Less, Interact and Move More (SLIMM) 2 Study

* Prolonged sitting (sedentary behavior) is a risk factor for decreased kidney function, obesity, diabetes and mortality. Prolonged sitting is associated with …

Chronic Kidney DiseasesObesity

Srinvasan BeddhuNCT05173714

~$10 – $7,500

Phase 2

Therapeutic Targeting of Gasdermin D-Mediated Pyroptosis to Attenuate Joint Inflammation in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent joint inflammation and systemic immune activation. Obesity is common amon…

Rheumatoid ArthritisInflammationObesity

University of OklahomaNCT07534332

Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

This study examines how adults who take a GLP-1 receptor agonist medication (such as semaglutide \[Ozempic, Wegovy, Rybelsus\], liraglutide \[Saxenda, Victoza\…

Obesity & OverweightDiabetes (DM)